WATSON 3613 Pill - beige oval
Pill with imprint WATSON 3613 is Beige, Oval and has been identified as Ropinirole Hydrochloride Extended-Release 4 mg. It is supplied by Watson Laboratories, Inc.
Ropinirole is used in the treatment of Restless Legs Syndrome; Periodic Limb Movement Disorder; Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3613
Ropinirole Hydrochloride Extended-Release
- Imprint
- WATSON 3613
- Strength
- 4 mg
- Color
- Beige
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3613 (Discontinued)
- Inactive Ingredients
-
hypromelloses,
mannitol,
glyceryl dibehenate,
lactose monohydrate,
hydrogenated castor oil,
povidone,
sodium lauryl sulfate,
magnesium silicate,
magnesium stearate,
silicon dioxide,
triethyl citrate,
titanium dioxide,
polydextrose,
triacetin,
polyethylene glycol 8000,
FD&C Yellow No. 6,
FD&C Blue No. 2,
aluminum oxide,
vinyl acetate
Note: Inactive ingredients may vary.
More about ropinirole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (328)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
